Literature DB >> 19603491

Comparison of the internalization of targeted dendrimers and dendrimer-entrapped gold nanoparticles into cancer cells.

Xiangyang Shi1, Su He Wang, Inhan Lee, Mingwu Shen, James R Baker.   

Abstract

Dendrimer-based nanotechnology significantly advances the area of targeted cancer imaging and therapy. Herein, we compared the difference of surface acetylated fluorescein isocyanate (FI) and folic acid (FA) modified generation 5 (G5) poly(amidoamine) dendrimers (G5.NHAc-FI-FA), and dendrimer-entrapped gold nanoparticles with similar modifications ([(Au(0))(51.2)-G5.NHAc-FI-FA]) in terms of their specific internalization to FA receptor (FAR)-overexpressing cancer cells. Confocal microscopic studies show that both G5.NHAc-FI-FA and [(Au(0))(51.2-)G5.NHAc-FI-FA] exhibit similar internalization kinetics regardless of the existence of Au nanoparticles (NPs). Molecular dynamics simulation of the two different nanostructures reveals that the surface area and the FA moiety distribution from the center of the geometry are slightly different. This slight difference may not be recognized by the FARs on the cell membrane, consequently leading to similar internalization kinetics. This study underlines the fact that metal or inorganic NPs entrapped within dendrimers interact with cells in a similar way to that of dendrimers lacking host NPs. 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19603491      PMCID: PMC2901835          DOI: 10.1002/bip.21279

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  11 in total

1.  Mannose functionalization of a sixth generation dendrimer.

Authors:  E K Woller; M J Cloninger
Journal:  Biomacromolecules       Date:  2001       Impact factor: 6.988

2.  The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.

Authors:  Seungpyo Hong; Pascale R Leroueil; István J Majoros; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Chem Biol       Date:  2007-01

3.  Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.

Authors:  Jolanta F Kukowska-Latallo; Kimberly A Candido; Zhengyi Cao; Shraddha S Nigavekar; Istvan J Majoros; Thommey P Thomas; Lajos P Balogh; Mohamed K Khan; James R Baker
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

4.  Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy.

Authors:  István J Majoros; Thommey P Thomas; Chandan B Mehta; James R Baker
Journal:  J Med Chem       Date:  2005-09-22       Impact factor: 7.446

5.  Targeting and inhibition of cell growth by an engineered dendritic nanodevice.

Authors:  Thommey P Thomas; Istvan J Majoros; Alina Kotlyar; Jolanta F Kukowska-Latallo; Anna Bielinska; Andrzej Myc; James R Baker
Journal:  J Med Chem       Date:  2005-06-02       Impact factor: 7.446

6.  Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly(amidoamine) dendrimer-stabilized iron oxide nanoparticles.

Authors:  Xiangyang Shi; Thommey P Thomas; Lukasz A Myc; Alina Kotlyar; James R Baker
Journal:  Phys Chem Chem Phys       Date:  2007-09-07       Impact factor: 3.676

7.  Synthesis, characterization and stability of a luteinizing hormone-releasing hormone (LHRH)-functionalized poly(amidoamine) dendrimer conjugate.

Authors:  Xiangdong Bi; Xiangyang Shi; James R Baker
Journal:  J Biomater Sci Polym Ed       Date:  2008       Impact factor: 3.517

8.  PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.

Authors:  István J Majoros; Andrzej Myc; Thommey Thomas; Chandan B Mehta; James R Baker
Journal:  Biomacromolecules       Date:  2006-02       Impact factor: 6.988

9.  Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging.

Authors:  Xiangyang Shi; Suhe Wang; Sasha Meshinchi; Mary E Van Antwerp; Xiangdong Bi; Inhan Lee; James R Baker
Journal:  Small       Date:  2007-07       Impact factor: 13.281

10.  Spontaneous Formation of Functionalized Dendrimer-Stabilized Gold Nanoparticles.

Authors:  Xiangyang Shi; Kai Sun; James R Baker
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2009-05-08       Impact factor: 4.126

View more
  6 in total

1.  Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review.

Authors:  Jie Liu; Warren D Gray; Michael E Davis; Ying Luo
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

Review 2.  Nanotechnology in corneal neovascularization therapy--a review.

Authors:  Lilian Gonzalez; Raymond J Loza; Kyu-Yeon Han; Suhair Sunoqrot; Christy Cunningham; Patryk Purta; James Drake; Sandeep Jain; Seungpyo Hong; Jin-Hong Chang
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-20       Impact factor: 2.671

3.  PEGylated dendrimer-entrapped gold nanoparticles with low immunogenicity for targeted gene delivery.

Authors:  Bei Xu; Aijun Li; Xinxin Hao; Rui Guo; Xiangyang Shi; Xueyan Cao
Journal:  RSC Adv       Date:  2018-01-03       Impact factor: 4.036

Review 4.  Cancer active targeting by nanoparticles: a comprehensive review of literature.

Authors:  Remon Bazak; Mohamad Houri; Samar El Achy; Serag Kamel; Tamer Refaat
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-09       Impact factor: 4.553

5.  Multifunctional dendrimer/combretastatin A4 inclusion complexes enable in vitro targeted cancer therapy.

Authors:  Mengen Zhang; Rui Guo; Yin Wang; Xueyan Cao; Mingwu Shen; Xiangyang Shi
Journal:  Int J Nanomedicine       Date:  2011-10-14

6.  Effective CpG Delivery Using Zwitterion-Functionalized Dendrimer-Entrapped Gold Nanoparticles to Promote T Cell-Mediated Immunotherapy of Cancer Cells.

Authors:  Huan Chen; Yiming Zhang; Lulu Li; Rui Guo; Xiangyang Shi; Xueyan Cao
Journal:  Biosensors (Basel)       Date:  2022-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.